Please login to the form below

Free Thinking: Are biosimilars the answer to the rising cost of RA treatment?


In a past Free Thinking paper, we looked at the opportunity and challenges for biosimilar mAbs entering the rheumatoid arthritis market. A few years later and according to our Therapy Watch patient record data, uptake of biosimilars remains relatively muted, with marked inconsistencies across the major European markets. With Enbrel biosimilar Benepali about to launch across EU, we ask what’s next for RA?

http://www.researchpartnership.com/news/2016/04/ft-are-biosimilars-the-answer-to-the-rising-cost-of-...


3rd June 2016

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

News:
Therapy Watch COVID-19 tracker
Research Partnership
Events:
Patient Centricity and Engagement Conference 2021
Research Partnership
Webinar:
UX beyond the website: Insights for the age of omnichannel
Research Partnership
News:
MedTech Qualitative Specialist joins Research Partnership
Research Partnership
Guide
How to embrace behavioural science principles in healthcare MR
Research Partnership
Article
A glimmer of hope for Alzheimer’s patients, but at what cost?
Research Partnership